Ayasdi is an advanced analytics company that offers a machine intelligence platform and intelligent applications to Global 500 corporations, governments and scientific research institutions around the world. Our clients use Ayasdi to solve their big data and complex data analytics challenges and to automate formerly manual processes using their own unique data. Ayasdi’s machine intelligence platform combines scalable computing and big data infrastructure with the latest machine learning, statistical and geometric algorithms and Topological Data Analysis to enable data scientists, domain experts and business people to be exponentially more productive.
Ayasdi is licensed on an annual subscription basis, and can be deployed on premise, or via private or public cloud infrastructures.
Gunnar Carlsson, Harlan Sexton, and Benjamin Mann met as Ph.D. mathematics students at Stanford University…
They conceptualized computational topology and Topological Data Analysis, which today is a core part of the Ayasdi machine intelligence platform.
US government research agencies DARPA and NSF award $10M in grants to Stanford, with Gunnar Carlsson as the principal investigator, to apply Topological Data Analysis (TDA) to real world problems. Gunnar invites Ayasdi co-founder Harlan Sexton to work with him on the project.
Stanford Ph.D. mathematics student, Gurjeet Singh, joins his professor Gunnar Carlsson on the Topological Data Analysis research project.
Gurjeet Singh creates the first software program applying Topological Data Analysis to real-world problems: Mapper.
Gurjeet, Gunnar and Harlan founded Ayasdi to commercialize Topological Data Analysis.
Ayasdi receives a $2 million seed round of capital from FLOODGATE.
Khosla Ventures leads a $10M Series A round.
Steve Harrick of IVP joins the Board.
Ayasdi Cure is a suite of intelligent applications for pharmaceutical companies focused on biomarker identification, drug target discovery, and precision medicine.
Ayasdi Care is a suite of intelligent applications for healthcare companies focused on clinical variation, claims reimbursement, population health and precision medicine.
Kleiner Perkins Caufield & Byers, Centerview Capital, and DraperNexus invest in Ayasdi.